Funding Rounds

Phagenesis

Phagenesis Series D (2024, $42M)

Developer of neurostimulation system to treat swallowing dysfunction.

View Company Profile

Summary

Stage: Series D

Raised Amount: $42.00M

Raised Date: 2024-04-01

Investors

EQT Life Sciences
( 32 )

British Patient Capital
( 35 )

Northern Gritstone
( 20 )

Sectoral Asset Management
( 33 )